Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT201308095381N7Phase 3Completed
Phase 3, randomised trial in None comparing Dexmedetomidine arm with Midazolam arm (2 arms). Primary endpoint: Sedation efficacy. Started Jun 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT201308095381N7.